Clinical value of pre-operative scoring systems to predict leiomyosarcoma: results of a validation study in 177 patients from the NOGGO-REGSA Registry.

Mateja CondicEva Katharina EggerPeter HohenbergerChristian StaerkAndreas MayrRobert ArmbrustEva RoserAlexander MusteaJalid Sehouli

Published in: International journal of gynecological cancer : official journal of the International Gynecological Cancer Society (2022)

In our validation cohort, the pLMS score seems not to be a reliable tool to predict leiomyosarcoma and therefore we do not recommend its clinical implementation to identify leiomyosarcoma.

Keyphrases

end stage renal disease
newly diagnosed
ejection fraction
chronic kidney disease
primary care
peritoneal dialysis
prognostic factors
quality improvement
patient reported